These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32072352)

  • 1. Treatment of hypophosphatasia.
    Simon S; Resch H
    Wien Med Wochenschr; 2020 Apr; 170(5-6):112-115. PubMed ID: 32072352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypophosphatasia: From Diagnosis to Treatment.
    Simon S; Resch H; Klaushofer K; Roschger P; Zwerina J; Kocijan R
    Curr Rheumatol Rep; 2018 Sep; 20(11):69. PubMed ID: 30203264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypophosphatasia.
    Mornet E
    Orphanet J Rare Dis; 2007 Oct; 2():40. PubMed ID: 17916236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.
    Bowden SA; Foster BL
    Adv Exp Med Biol; 2019; 1148():279-322. PubMed ID: 31482504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme replacement therapy for hypophosphatasia-The current paradigm.
    Schindeler A; Ludwig K; Munns CF
    Clin Endocrinol (Oxf); 2024 Jul; ():. PubMed ID: 39004952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypophosphatasia in Adults: Clinical Assessment and Treatment Considerations.
    Shapiro JR; Lewiecki EM
    J Bone Miner Res; 2017 Oct; 32(10):1977-1980. PubMed ID: 28731215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.
    Kishnani PS; Rush ET; Arundel P; Bishop N; Dahir K; Fraser W; Harmatz P; Linglart A; Munns CF; Nunes ME; Saal HM; Seefried L; Ozono K
    Mol Genet Metab; 2017 Sep; 122(1-2):4-17. PubMed ID: 28888853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypophosphatasia: A Unique Disorder of Bone Mineralization.
    Villa-Suárez JM; García-Fontana C; Andújar-Vera F; González-Salvatierra S; de Haro-Muñoz T; Contreras-Bolívar V; García-Fontana B; Muñoz-Torres M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asfotase alfa: enzyme replacement for the treatment of bone disease in hypophosphatasia.
    Hofmann C; Seefried L; Jakob F
    Drugs Today (Barc); 2016 May; 52(5):271-85. PubMed ID: 27376160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypophosphatasia: Canadian update on diagnosis and management.
    Khan AA; Josse R; Kannu P; Villeneuve J; Paul T; Van Uum S; Greenberg CR
    Osteoporos Int; 2019 Sep; 30(9):1713-1722. PubMed ID: 30915507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone healing and reactivation of remodeling under asfotase alfa therapy in adult patients with pediatric-onset hypophosphatasia.
    Stürznickel J; Schmidt FN; von Vopelius E; Delsmann MM; Schmidt C; Jandl NM; Oheim R; Barvencik F
    Bone; 2021 Feb; 143():115794. PubMed ID: 33301963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypophosphatasia : What is currently available for treatment?].
    Schmidt T; Amling M; Barvencik F
    Internist (Berl); 2016 Dec; 57(12):1145-1154. PubMed ID: 27796472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asfotase alfa therapy for children with hypophosphatasia.
    Whyte MP; Madson KL; Phillips D; Reeves AL; McAlister WH; Yakimoski A; Mack KE; Hamilton K; Kagan K; Fujita KP; Thompson DD; Moseley S; Odrljin T; Rockman-Greenberg C
    JCI Insight; 2016 Jun; 1(9):e85971. PubMed ID: 27699270
    [No Abstract]   [Full Text] [Related]  

  • 14. Pediatric hypophosphatasia: lessons learned from a retrospective single-center chart review of 50 children.
    Vogt M; Girschick H; Schweitzer T; Benoit C; Holl-Wieden A; Seefried L; Jakob F; Hofmann C
    Orphanet J Rare Dis; 2020 Aug; 15(1):212. PubMed ID: 32811521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypophosphatasia: An overview For 2017.
    Whyte MP
    Bone; 2017 Sep; 102():15-25. PubMed ID: 28238808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia.
    Scott LJ
    Drugs; 2016 Feb; 76(2):255-62. PubMed ID: 26744272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypophosphatasia.
    Rockman-Greenberg C
    Pediatr Endocrinol Rev; 2013 Jun; 10 Suppl 2():380-8. PubMed ID: 23858621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypophosphatasia: presentation and response to asfotase alfa.
    Alsarraf F; Ali DS; Almonaei K; Al-Alwani H; Khan AA; Brandi ML
    Osteoporos Int; 2024 Apr; 35(4):717-725. PubMed ID: 37993691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasia.
    Dahir KM; Shannon A; Dunn D; Voegtli W; Dong Q; Hasan J; Pradhan R; Pelto R; Pan WJ
    J Bone Miner Res; 2024 Sep; 39(10):1412-1423. PubMed ID: 39135540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme-replacement therapy in perinatal hypophosphatasia: Case report and review of the literature.
    Rougier H; Desrumaux A; Bouchon N; Wroblewski I; Pin I; Nugues F; Mornet E; Baujat G
    Arch Pediatr; 2018 Oct; 25(7):442-447. PubMed ID: 30249491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.